# Safety and Tolerability of Lu AG06479 in Healthy Young Men

> **NCT04473651** · PHASE1 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lu AG06479
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04473651
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-09
- **Primary completion:** 2021-11-10
- **Final completion:** 2021-11-10
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** The study was terminated for strategic reasons.
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473651, "Safety and Tolerability of Lu AG06479 in Healthy Young Men". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04473651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*